Context: Things have not gone well so far for Alexion Pharmaceuticals’ patent infringement actions against Amgen and Samsung Bioepis. Six months ago, the Unified Patent Court’s (UPC) Court of Appeal
The German pharmaceutical company Merz has filed a PI action against Viatris at the Paris local division. According to JUVE Patent information, this marks the first SPC case at the UPC. Does the
Frohwitter’s company Partec and its exclusive licensee BF exaQC AG filed a third complaint with the UPC against semiconductor manufacturer Nvidia last Friday. Like two previous actions, the suit filed with
The UK's ratification of an international agreement to establish a new Unified Patent Court (UPC) in Europe has moved closer following recent actions taken by parliament and the Privy Council. The
In the dispute between MyStromer and Revolt Zykling over e-bike technology, the Düsseldorf local division has imposed the first penalty payment in a UPC case. This follows the UPC's first ex parte
the appeal proceedings between 10X Genomics and NanoString. The court’s local division in Munich had heard the preliminary injunction dispute in December. NanoString informed JUVE Patent that the UPC
, with Carpmaels & Ransford instead taking over the defence. The case marks the first time that a UK law firm will conduct UPC proceedings completely independently. At the Unified Patent Court, US-based
The UPC Munich local division issued a clear injunction in the dispute between two companies from the plant protection industry and upheld the patent. The judges also commented on the two-month
(Amgen first sued Sanofi and Regeneron in the U.S. in 2014). In another recent prong of the dispute, Sanofi sued Amgen in the Unified Patent Court’s (UPC) Dusseldorf Local Division (LD) over the
Roche Diagnostics has now resolved its UPC dispute with Tandem Diabetes Care, VitalAire and other defendants with a settlement. The case was playing out in Hamburg, Düsseldorf and Paris. Since late